logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Repros Jumps on Positive Drug Trials

By  +Follow September 17, 2013 8:01AM
Share:
Tickers Mentioned:

Shares in Texas pharma Repros Therapeutics, Inc. (RPRX) gapped up over 30 percent in early morning trading before settling into gains of just over 10 percent on heavy volume as the day wore on. The spike, driven by positive topline results from the most recent study on its drug Androxal® reported after close on Monday, pushed Repros stock to a new 52-week high.

Positive results for Androxal

Androxal is being developed for men of reproductive age with low testosterone due to secondary hypogonadism, which is also associated with obesity and could be among the most common causes of low testosterone. Repros reported that Andorxal met both co-primary endpoints in its second pivotal study, with 81 percent of subjects using the drug experiencing normalized testosterone and no 24-hour average testosterone levels outside of normal ranges. Androxal, which is in a class similar to Sanofi’s (SNY) Clomid®, could receive a strong share of the testosterone replacement therapy (TRT) market because it could also help preserve male fertility while being administered orally, making it significantly more convenient than testosterone replacement injections.  

Possible Sale

Brean Capital initiated coverage of Repros in July of this year, calling it a buy and setting a price target of $32. At the time, analyst Jonathan Aschoff said “Its lead compound Androxal is being evaluated in a Phase 3 program for secondary hypogonadism with results in 4Q13 and 2Q14, which in our view would be key investment catalysts, and we project Androxal launch in mid-2015.” Now, Brean is citing these positive results as a reason for optimism, as well as reports that management may have interest in selling the company. Brean estimated the sell-price potentially reaching $40 a share, in the event that the sale goes down.

In addition to Andorxal, Repros currently has female reproductive drug Proellex® in the pipeline, intended for use in uterine fibroids and endometriosis. “The vaginal formulation of Proellex (Proellex-V) will enter Phase 2b in 2H13 for uterine fibroids with an NDA submission expected in 2016. All compounds are protected by U.S. patents," said Aschoff in July.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for RPRX
Stockaholics
17 Dec 14 14:40:59
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/BuDJZVQmcq $ANAC $ACTV $RPRX
DailyStockPicks
17 Dec 14 14:21:10
$ECIG buyout target of $0.50. 400% upside. Positive EBITDA and $200MM revenue in 2015 $SWC $UNIS $RPRX traders read: http://t.co/xi3978GuDs
Daily Contracts
17 Dec 14 13:40:02
Real-Time feed of company contracts, original agreements and executive updates from Repros Therapeutics Inc. $RPRX http://t.co/pdlwyiAIm8
AdamSam
17 Dec 14 12:06:36
$SPHS looks ready for a nice bounce, developed good base support in .47 - .51 range. good bid support. On bounce watch. $RPRX $CLDX $ACHN
Penny Stock Secret
17 Dec 14 09:30:34
The Stock Picking Service of 2014 More Info Here http://t.co/SVqoMlijqL ... $ANAC $ACTV $RPRX
Stockaholics
17 Dec 14 06:50:13
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Stockaholics
16 Dec 14 14:09:54
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/BuDJZVQmcq $ANAC $ACTV $RPRX
equities.com
16 Dec 14 11:42:15
Repros Therapeutics Inc. (RPRX) Drops 5.1% on November 28 $RPRX http://t.co/l662as4bac
David Buckingham
16 Dec 14 08:55:40
RT @Bull_Line: Solid day for: $SO $JDST $BABA $DGLY $CISG $CALA $ZAZA $PQ $ACHN $RMTI $NVAX $PLUG $RPRX $TLM $BAC $PBR $QQQ $AAPL $SIRII $N…
Bull Line Associates
16 Dec 14 08:35:59
Solid day for: $SO $JDST $BABA $DGLY $CISG $CALA $ZAZA $PQ $ACHN $RMTI $NVAX $PLUG $RPRX $TLM $BAC $PBR $QQQ $AAPL $SIRII $NVGN $HTA
Stockaholics
15 Dec 14 23:55:21
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Stockaholics
15 Dec 14 19:56:03
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Stockaholics
15 Dec 14 13:43:44
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Bio Penny Picks
15 Dec 14 09:56:07
$RPRX Would love to be playing this again.
Penny Stock Secret
15 Dec 14 07:38:45
The Stock Picking Service of 2014 More Info Here http://t.co/SVqoMlijqL .. $ANAC $ACTV $RPRX
Daily Contracts
15 Dec 14 07:07:02
Real-Time feed of company contracts, original agreements and executive updates from Repros Therapeutics Inc. $RPRX http://t.co/pdlwyiAIm8
Lawrence Hawkins
15 Dec 14 06:55:23
$LPCN FDA confirmation. Similar news from $RPRX was worth nearly $100mm in market cap on 11/7. Stock should be up big today.
Stockaholics
14 Dec 14 20:35:18
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Stockaholics
14 Dec 14 13:39:29
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Stockaholics
14 Dec 14 05:52:29
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Stockaholics
13 Dec 14 23:53:43
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Gary Manzano
13 Dec 14 11:01:34
@canuck2usa $RPRX looks interesting here. http://t.co/Hr8h2bafB9
Stockaholics
12 Dec 14 16:49:23
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
TickerChirp
12 Dec 14 13:02:03
Top in Twitter About $RPRX (Repros Therapeutics Inc symbol RPRX) on 12/12/2014 http://t.co/hQN1UUBSYq
Daily Contracts
12 Dec 14 12:16:01
Real-Time feed of company contracts, original agreements and executive updates from Repros Therapeutics Inc. $RPRX http://t.co/pdlwyiAIm8
AdamSam
12 Dec 14 11:51:33
$RPRX strong in this down market. $LOCO $FRO $DGLY and watching $CCXI and $SYN
BNK Invest
12 Dec 14 11:45:08
$RPRX Insiders vs. Shorts #stocks http://t.co/f6lXqBdHeF
Bio Penny Picks
12 Dec 14 07:05:38
$RPRX Got this one back on watch !
Penny Stock Secret
12 Dec 14 06:58:49
Yesterday We Made $89,000 In Just One Trade More Info Here http://t.co/SVqoMlijqL .. $ANAC $ACTV $RPRX
Stockaholics
12 Dec 14 05:14:43
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Stockaholics
11 Dec 14 15:09:33
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Stockaholics
11 Dec 14 09:59:02
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
danrocks
11 Dec 14 09:17:40
Right now RPRX is number 114 for the largest percentage gain out of 250 stocks. $RPRX RPRX is up +8.83% in the http://t.co/602RgO2Z7O
danrocks
11 Dec 14 09:17:18
$RPRX RPRX Stock is number 114 for the largest percentage gain out of 250 stocks. $RPRX RPRX is up +8.83% in the las http://t.co/hBKj3w4L8e
Penny Stock Secret
11 Dec 14 09:01:58
This Guy Is Making Millions! Watch This Video Proof Here At http://t.co/SVqoMlijqL .. $ANAC $ACTV $RPRX
Stockaholics
11 Dec 14 05:27:58
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Stockaholics
10 Dec 14 19:10:04
Platinum Memberships Rose, After 528% Gains On Penny Stocks, In One Month! Big Update: http://t.co/2W3yKD2d5Q $ANAC $ACTV $RPRX
Daily Contracts
10 Dec 14 12:36:02
Real-Time feed of company contracts, original agreements and executive updates from Repros Therapeutics Inc. $RPRX http://t.co/pdlwyiAIm8
danrocks
10 Dec 14 09:49:31
Right now RPRX is number 133 for the largest percentage gain out of 250 stocks. $RPRX RPRX is up +8.10% in the http://t.co/mcDiJKuM6Z
danrocks
10 Dec 14 09:49:09
$RPRX RPRX Stock is number 133 for the largest percentage gain out of 250 stocks. $RPRX RPRX is up +8.10% in the las http://t.co/hLTWpDliQ3
equities.com
10 Dec 14 06:47:55
Repros Therapeutics Inc. (RPRX) Jumps 6.67% on December 09 $RPRX http://t.co/LYX8LNqoNg
ProVesting
10 Dec 14 00:35:02
$RPRX $LFL: First Call Consensus: Repros Therapeutics Inc , Latam Airlines ... http://t.co/8pQe60SPlx http://t.co/EYakzf0bOa
				
				
By  +Follow September 17, 2013 8:01AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.